Inventor · disambiguated record
Seth Lederman
Also filed as: LEDERMAN SETH · LEDERMAN SETH M
33 granted patents·42 pending applications·797 citations·filing 1991–2025
98Inventor score
Files withUNIV COLUMBIA15TONIX PHARMA HOLDINGS LTD12TONIX Pharmaceuticals Holding Corp12LEDERMAN SETH7FOLLICA INC5
Top patents by PatentIndex Score
75 records- 0197US5474771AMurine monoclonal antibody (5c8) recognizes a human glycoprotein on the surface of T-lymphocytes, compositions containing sameUNIV COLUMBIA·Filed 1991·Granted Dec 12, 1995·152 cites·14 claims
- 0294US6358944B1Methods and compositions for treating generalized anxiety disorderVELA PHARMACEUTICALS INC·Filed 2000·Granted Mar 19, 2002·107 cites·21 claims
- 0393US10357465B2Eutectic formulations of cyclobenzaprine hydrochlorideTONIX PHARMA HOLDINGS LTD·Filed 2015·Granted Jul 23, 2019·14 cites·14 claims
- 0493US6793924B2Protein recognized by an antibody that specifically binds an epitope that is specifically bound by monoclonal antibody 5c8.UNIV COLUMBIA·Filed 2002·Granted Sep 21, 2004·31 cites·6 claims
- 0592US8093300B2Compositions and methods for increasing compliance with therapies using aldehyde dehydrogenase inhibitors and treating alcoholismLEDERMAN SETH·Filed 2008·Granted Jan 10, 2012·18 cites·6 claims
- 0692US5756710APhosphorothioate oligonucleotides that bind to the V3-loop and uses thereofUNIV COLUMBIA·Filed 1996·Granted May 26, 1998·147 cites·13 claims
- 0789US11026898B2Eutectic formulations of cyclobenzaprine hydrochlorideTONIX PHARMA HOLDINGS LTD·Filed 2019·Granted Jun 8, 2021·6 cites·23 claims
- 0889US9474728B2Methods and compositions for treating fatigue associated with disordered sleep using very low dose cyclobenzaprineTONIX PHARMA HOLDINGS LTD·Filed 2014·Granted Oct 25, 2016·15 cites·2 claims
- 0988US6610294B1Methods of inhibiting an autoimmune response in a human suffering from an autoimmune disease by administering an antibody that binds to a protein to which monoclonal antibody 5C8 bindsUNIV COLUMBIA·Filed 1992·Granted Aug 26, 2003·36 cites·16 claims
- 1088US6403091B1Methods for inhibiting the rejection of a transplant organ in a subject with 5C8-specific antibodiesUNIV COLUMBIA·Filed 1995·Granted Jun 11, 2002·42 cites·13 claims
- 1187US6451310B1Method for inhibiting an allergic response with a 5c8-specific antibodyUNIV COLUMBIA·Filed 1995·Granted Sep 17, 2002·41 cites·15 claims
- 1286US9918948B2Methods and compositions for treating symptoms associated with post-traumatic stress disorder using cyclobenzaprineLEDERMAN SETH·Filed 2010·Granted Mar 20, 2018·12 cites·11 claims
- 1385US6455044B15c8 antigenUNIV COLUMBIA·Filed 1999·Granted Sep 24, 2002·33 cites·5 claims
- 1484US12263323B2Methods for treating baldness and promoting hair growthFOLLICA INC·Filed 2021·Granted Apr 1, 2025·1 cites·14 claims
- 1584US6592868B1Methods for treating autoimmune diseases with 5C8-specific antibodiesUNIV COLUMBIA·Filed 1995·Granted Jul 15, 2003·33 cites·18 claims
- 1683US12365879B2Synthetic chimeric poxvirusesTONIX PHARMA LTD·Filed 2022·Granted Jul 22, 2025·1 cites·20 claims
- 1783US11207511B2Methods for treating baldness and promoting hair growthFOLLICA INC·Filed 2018·Granted Dec 28, 2021·2 cites·19 claims
- 1882US6340459B1Therapeutic applications for the anti-T-BAM (CD40-L) monoclonal antibody 5C8 in the treatment of reperfusion injury in non-transplant recipientsUNIV COLUMBIA·Filed 1996·Granted Jan 22, 2002·53 cites·23 claims
- 1981US10722478B2Methods and compositions for treating fatigue associated with disordered sleep using very low dose cyclobenzaprineTONIX PHARMA HOLDINGS LTD·Filed 2019·Granted Jul 28, 2020·2 cites·5 claims
- 2078US11345896B2Synthetic chimeric poxvirusesEVANS DAVID·Filed 2017·Granted May 31, 2022·1 cites·20 claims
- 2176US2025073204A1Analogs of cyclobenzaprine and amitryptileneTONIX Pharmaceuticals Holding Corp·Filed 2024·Application pending·0 cites
- 2273US12156864B2Analogs of cyclobenzaprine and amitryptileneTONIX Pharmaceuticals Holding Corp·Filed 2022·Granted Dec 3, 2024·0 cites·14 claims
- 2372US11826321B2Cyclobenzaprine treatment for agitation, psychosis and cognitive decline in dementia and neurodegenerative conditionsTONIX PHARMA HOLDINGS LTD·Filed 2018·Granted Nov 28, 2023·1 cites·7 claims
- 2472US2021128495A1Methods and compositions for treating fatigue associated with disordered sleep using very low dose cyclobenzaprineTONIX PHARMA HOLDINGS LTD·Filed 2020·Application pending·0 cites
- 2570US2025322926A1Early onset response, favorable tolerability, and side effect profile in the treatment of fibromyalgiaTONIX Pharmaceuticals Holding Corp·Filed 2024·Application pending·0 cites
- 2666US6331433B1Human T cell leukemia cell line designated D1.1UNIV COLUMBIA·Filed 1999·Granted Dec 18, 2001·10 cites·4 claims
- 2766US6331615B1Nucleic acid molecule encoding heavy or light chain of an antibody which specifically recognizes a protein specifically recognized by monoclonal antibody 5c8 (anti-CD40 ligand)UNIV COLUMBIA·Filed 1999·Granted Dec 18, 2001·10 cites·12 claims
- 2866US5993816AMethods to inhibit humoral immune responses, immunoglobulin production and B cell activation with 5c8-specific antibodiesTRUSTEES OF COLUMBIA UNVERSITY·Filed 1995·Granted Nov 30, 1999·13 cites·14 claims
- 2964US8481599B2Compositions and methods for increasing compliance with therapies using aldehyde dehydrogenase inhibitors and treating alcoholismLEDERMAN SETH·Filed 2011·Granted Jul 9, 2013·0 cites·11 claims
- 3063US11517557B2Analogs of cyclobenzaprine and amitriptylineTONIX Pharmaceuticals Holding Corp·Filed 2018·Granted Dec 6, 2022·0 cites·21 claims
- 3163US2025262168A1Combination therapeutic regimens with 1,6-dibromo-1,6-dideoxy-dulcitolEleison Pharmaceuticals LLC·Filed 2025·Application pending·0 cites
- 3262US2005037005A15c8 AntigenUNIV COLUMBIA·Filed 2004·Application pending·0 cites
- 3362US2023414536A1CYCLOBENZAPRINE TREATMENT FOR POST-ACUTE SEQUELAE OF (SARS)-CoV-2 INFECTION (PASC)TONIX Pharmaceuticals Holding Corp·Filed 2023·Application pending·0 cites
- 3461US2006110392A1Murine monoclonal antibody (5c8) recognizes T-B cell activating molecule (T-BAM) (CD40 LIGAND) on the surface of T-lymphocytes, compositions containing same and methods of useUNIV COLUMBIA·Filed 2004·Application pending·0 cites
- 3560US2022142941A1Combination therapeutic regimens with 1,6-dibromo-1,6-dideoxy-dulcitolEleison Pharmaceuticals LLC·Filed 2020·Application pending·0 cites
- 3658US2024059781A1Methods of inducing immune tolerance with modified anti-cd154 antibodiesTONIX PHARMA LTD·Filed 2022·Application pending·0 cites
- 3758US2005118166A1Therapeutic applications for the anti-T-BAM (CD40-1) monoclonal antibody 5C8BIOGEN INC·Filed 2003·Application pending·0 cites
- 3857US7070777B1Method for inhibiting inflammation with an antibody that binds the 5C8 proteinUNIV COLUMBIA·Filed 1995·Granted Jul 4, 2006·15 cites·10 claims
- 3956US2024024256A1Cyclobenzaprine treatment for fibromyalgiaTONIX Pharmaceuticals Holding Corp·Filed 2021·Application pending·0 cites
- 4054US2017065538A1Methods and compositions for treating fatigue associated with disordered sleep using very low dose cyclobenzaprineTONIX PHARMA HOLDINGS LTD·Filed 2016·Application pending·0 cites
- 4154US2024165126A1Tianeptine oxalate and naloxone combination for the treatment of major depressive disorderTONIX Pharmaceuticals Holding Corp·Filed 2022·Application pending·0 cites
- 4253US2021236619A1Stem cells comprising synthetic chimeric vaccinia virus and methods of using themTONIX PHARMA HOLDINGS LTD·Filed 2019·Application pending·0 cites
- 4353US2022380478A1Anti-cd154 antibodies and uses thereofTONIX PHARMA HOLDINGS LTD·Filed 2020·Application pending·0 cites
- 4452US2011319389A1Methods and compositions for treating fatigue associated with disordered sleep using very low dose cyclobenzaprineLEDERMAN SETH·Filed 2011·Application pending·0 cites
- 4552US2003087814A1Compositions and methods for increasing compliance with therapies using aldehyde dehydrogenase inhibitors and treating alcoholismFiled 2002·Application pending·0 cites
- 4651US11998516B2Methods and compositions for treating depression using cyclobenzaprineLEDERMAN SETH·Filed 2012·Granted Jun 4, 2024·0 cites·6 claims
- 4751US2021260182A1RECOMBINANT POXVIRUS BASED VACCINE AGAINST SARS-CoV-2 VIRUSGOEBEL SCOTT J·Filed 2021·Application pending·0 cites
- 4851US2022016268A1Skin-based testing for detection of cell-mediated immune responses to sars-cov-2TONIX Pharmaceuticals Holding Corp·Filed 2021·Application pending·0 cites
- 4950US6849415B2TRAF-3 deletion isoforms and uses thereofUNIV COLUMBIA·Filed 2001·Granted Feb 1, 2005·0 cites·3 claims
- 5050US2024009146A1Cyclobenzaprine treatment for alcohol use disorderTONIX Pharmaceuticals Holding Corp·Filed 2021·Application pending·0 cites
Showing the top 50 of 75 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Seth Lederman files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →